Literature DB >> 20002510

An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in northern ireland (fleetwood northern ireland study).

Susan M Patterson1, Carmel M Hughes, Grainne Crealey, Chris Cardwell, Kate L Lapane.   

Abstract

OBJECTIVES: To test the effect of an adapted U.S. model of pharmaceutical care on prescribing of inappropriate psychoactive (anxiolytic, hypnotic, and antipsychotic) medications and falls in nursing homes for older people in Northern Ireland (NI).
DESIGN: Cluster randomized controlled trial.
SETTING: Nursing homes randomized to intervention (receipt of the adapted model of care; n=11) or control (usual care continued; n=11). PARTICIPANTS: Residents aged 65 and older who provided informed consent (N=334; 173 intervention, 161 control). INTERVENTION: Specially trained pharmacists visited intervention homes monthly for 12 months and reviewed residents' clinical and prescribing information, applied an algorithm that guided them in assessing the appropriateness of psychoactive medication, and worked with prescribers (general practitioners) to improve the prescribing of these drugs. The control homes received usual care. MEASUREMENTS: The primary end point was the proportion of residents prescribed one or more inappropriate psychoactive medicine according to standardized protocols; falls were evaluated using routinely collected falls data mandated by the regulatory body for nursing homes in NI.
RESULTS: The proportion of residents taking inappropriate psychoactive medications at 12 months in the intervention homes (25/128, 19.5%) was much lower than in the control homes (62/124, 50.0%) (odds ratio=0.26, 95% confidence interval=0.14-0.49) after adjustment for clustering within homes. No differences were observed at 12 months in the falls rate between the intervention and control groups.
CONCLUSION: Marked reductions in inappropriate psychoactive medication prescribing in residents resulted from pharmacist review of targeted medications, but there was no effect on falls.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002510     DOI: 10.1111/j.1532-5415.2009.02617.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  40 in total

Review 1.  The role of the pharmacist in optimizing pharmacotherapy in older people.

Authors:  Anne Spinewine; Daniela Fialová; Stephen Byrne
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

2.  A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.

Authors:  Luca Pasina; Alessandra Marengoni; Simona Ghibelli; Flavio Suardi; Codjo D Djade; Alessandro Nobili; Carlotta Franchi; Gianbattista Guerrini
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

Review 3.  Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia.

Authors:  Ramon Cacabelos
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 4.  Pharmacist services in nursing homes: A systematic review and meta-analysis.

Authors:  Shaun Wen Huey Lee; Vivienne Sook Li Mak; Yee Woon Tang
Journal:  Br J Clin Pharmacol       Date:  2019-11-03       Impact factor: 4.335

Review 5.  Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

Authors:  Mairead McGrattan; Cristín Ryan; Heather E Barry; Carmel M Hughes
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 6.  Pharmacy interventions on prescribing in nursing homes: from evidence to practice.

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Ther Adv Drug Saf       Date:  2011-06

Review 7.  Medication safety in residential aged-care facilities: a perspective.

Authors:  Nicholas M Wilson; Lyn M March; Philip N Sambrook; Sarah N Hilmer
Journal:  Ther Adv Drug Saf       Date:  2010-10

Review 8.  Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review.

Authors:  Marlies M E Geurts; Jaap Talsma; Jacobus R B J Brouwers; Johan J de Gier
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

Review 9.  A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.

Authors:  Jean-Baptiste Beuscart; Lisa G Pont; Stefanie Thevelin; Benoit Boland; Olivia Dalleur; Anne W S Rutjes; Johanna I Westbrook; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

10.  Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes.

Authors:  Kate L Lapane; Carmel M Hughes; Lori A Daiello; Kathleen A Cameron; Janice Feinberg
Journal:  J Am Geriatr Soc       Date:  2011-06-07       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.